What is a rural opioid risk and policy environment?

Richard A. Jenkins; Holly Hagan

doi:10.1016/j.drugpo.2019.11.014

What is a rural opioid risk and policy environment?

Richard A. Jenkins, Holly Hagan

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Article number	102606
Journal	International Journal of Drug Policy
Volume	85
DOIs	https://doi.org/10.1016/j.drugpo.2019.11.014
State	Published - Nov 2020

Keywords

Opioid
Policy environment
Rural risk environment

ASJC Scopus subject areas

Medicine (miscellaneous)
Health Policy

Access to Document

10.1016/j.drugpo.2019.11.014

Cite this

@article{769d3b3683a44ab1a4017d334eb68c5c,

title = "What is a rural opioid risk and policy environment?",

keywords = "Opioid, Policy environment, Rural risk environment",

author = "Jenkins, {Richard A.} and Holly Hagan",

note = "Funding Information: Preparation of this manuscript was supported by the following grants awarded by National Institute on Drug Abuse with cofounding from the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, and the Appalachian Regional Commission: U24DA048538, UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825, and U24DA044801. Support also was proviuded by P30DA011041. Dr. Richard Jenkins was substantially involved in all these grants consistent with his role as Scientific Officer, except P30 DA011041-21 where he had no substantial involvement. Disclaimer: The views and opinions expressed in this manuscript are those of the authors only and do not necessarily represent the views, official policy or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. Funding Information: Preparation of this manuscript was supported by the following grants awarded by National Institute on Drug Abuse with cofounding from the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration , and the Appalachian Regional Commission : U24DA048538, UG3DA044798, UG3DA044829, UG3DA044822, UG3DA044823, UG3DA044831, UG3DA044826, UG3DA044830, UG3DA044825, and U24DA044801 . Support also was proviuded by P30DA011041. Dr. Richard Jenkins was substantially involved in all these grants consistent with his role as Scientific Officer, except P30 DA011041-21 where he had no substantial involvement. Disclaimer: The views and opinions expressed in this manuscript are those of the authors only and do not necessarily represent the views, official policy or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. ",

year = "2020",

month = nov,

doi = "10.1016/j.drugpo.2019.11.014",

language = "English (US)",

volume = "85",

journal = "International Journal of Drug Policy",